Either amoxicillin or amoxicillin-clavulanate will clear infection, but the former is less likely to result in side-effects or antimicrobial resistance.
It provides evidence-based information to inform and educate healthcare professionals on the regulation and scientific basis for the authorization of biosimilars by Health Canada.